|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.1606 - 0.1720|
|52 Week Range||0.0600 - 0.4400|
|Beta (5Y Monthly)||-1.04|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 29, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
KINDERHOOK, NY / ACCESSWIRE / March 23, 2020 / American Bio Medica Corporation (OTC PINK:ABMC), a manufacturer of accurate, cost-effective immunoassay test kits, announced today that it began offering on March 17, 2020, via a distribution partnership, a Rapid Test to detect Covid-19 in whole blood, serum or plasma. The test has not yet been reviewed by the U.S. Food and Drug Administration (FDA), but is being offered under the March 16, 2020 guidance set forth by the FDA. To place an order, customers can call (800) 227-2343, or (518) 758-8158 outside the United States or, contact the company via email at COVID19@abmc.com.
KINDERHOOK, NY / ACCESSWIRE / November 14, 2019 / American Bio Medica Corporation (OTC PINK:ABMC) today announced financial results for the three and nine months ended September 30, 2019. Chief Executive ...
KINDERHOOK, NY / ACCESSWIRE / August 14, 2019 / American Bio Medica Corporation ( OTC PINK:ABMC ) today announced financial results for the three and six months ended June 30, 2019. Chief Executive Officer ...